7.4.5. Drugs for erectile dysfunction
Prescribing Notes:
Available for hospital and community prescribing but NHS prescribing by GPs is limited to nationally determined patient groups and schedule 11 restrictions. Please follow Board referral guidance for men suffering erectile dysfunction, including approval for GP prescribing for erectile dysfunction causing severe distress. Consult Summary of Product Characteristics on drug interactions prior to prescribing.

Restrictions:
Restricted to specialist initiation for use in patients who have failed on oral therapies (oral phosphodiesterase type-5 inhibitors) and other non-injectable formulations of erectile dysfunction medications.
Restrictions:
Restricted to use for erectile dysfunction or for pulmonary arterial hypertension (see section 2.4.1). Use for benign prostatic hyperplasia is not recommended for use by SMC and is non-Formulary.
Prescribing Notes:
Available for hospital and community prescribing but NHS prescribing by GPs is limited to nationally determined patient groups and schedule 11 restrictions. Please follow Board referral guidance for men suffering erectile dysfunction, including approval for GP prescribing for erectile dysfunction causing severe distress. Consult Summary of Product Characteristics on drug interactions prior to prescribing.
Restrictions:
Excludes orodispersible tablets.
Prescribing Notes:
Available for hospital and community prescribing but NHS prescribing by GPs is limited to nationally determined patient groups and schedule 11 restrictions. Please follow Board referral guidance for men suffering erectile dysfunction, including approval for GP prescribing for erectile dysfunction causing severe distress. Consult Summary of Product Characteristics on drug interactions prior to prescribing.